OTCMKTS:MCUJF Medicure (MCUJF) Stock Price, News & Analysis $0.80 0.00 (0.00%) (As of 09/13/2024 ET) Add Compare Share Share Today's Range$0.80▼$0.8050-Day Range$0.72▼$0.9052-Week Range$0.68▼$1.26VolumeN/AAverage Volume4,751 shsMarket Capitalization$8.35 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartEarningsFinancialsSEC FilingsShort InterestStock AnalysisChartEarningsFinancialsSEC FilingsShort Interest Get Medicure alerts: Email Address Ad Crypto 101 MediaTrader Books $13M Profit on “Nvidia of Crypto”A position trader recently booked an estimated $13.2 million profit on a single crypto currency… This little-known coin, dubbed the "Nvidia of crypto," is fueling the artificial intelligence boom – allowing top companies to train their AI systems without the need for expensive microchips.Click here to review my research and the strategy I've developed for the opportunity to trade this c About Medicure Stock (OTCMKTS:MCUJF)Medicure Inc., a biopharmaceutical company, engages in the research, development, and commercialization of human therapies for the cardiovascular market. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction. It also offers ZYPITAMAG to treat patients with primary hyperlipidemia or mixed dyslipidemia. In addition, the company offers Sodium Nitroprusside injection for the reduction of blood pressure for adult and pediatric patients in hypertensive crisis, as well as for producing controlled hypotension to reduce bleeding during surgery, and for the treatment of acute congestive heart failure. It offers products through retail and mail order pharmacies. The company was incorporated in 1997 and is headquartered in Winnipeg, Canada.Read More MCUJF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart MCUJF Stock News HeadlinesAugust 18, 2024 | finance.yahoo.comMedicure Second Quarter 2024 Earnings: CA$0.12 loss per share (vs CA$0.024 profit in 2Q 2023)August 15, 2024 | finanznachrichten.deMedicure, Inc.: Medicure Announces Closing of Asset Purchase Agreement with Canam Bioresearch for Acquisition of Intellectual PropertySeptember 16, 2024 | Crypto 101 Media (Ad)Trader Books $13M Profit on “Nvidia of Crypto”A position trader recently booked an estimated $13.2 million profit on a single crypto currency… This little-known coin, dubbed the "Nvidia of crypto," is fueling the artificial intelligence boom – allowing top companies to train their AI systems without the need for expensive microchips.May 28, 2024 | finance.yahoo.comMedicure Reports Financial Results for Quarter Ended March 31, 2024 and Annual General Meeting Director Election ResultsDecember 5, 2023 | finance.yahoo.comMedicure Announces New Partnership Through Its Marley Drug Subsidiary to Provide Brenzavvy(R) as an Affordable Medication for Americans with Type 2 DiabetesNovember 24, 2023 | msn.comMedicure approved to enrol patients in paediatric disease trialNovember 23, 2023 | benzinga.comMedicure Announces FDA Provides Complete Approval to Enroll Patients in Its Pivotal Phase 3 Trial for Treatment of Rare Pediatric DiseaseNovember 21, 2023 | msn.comMedicure GAAP EPS of C$0.01, revenue of C$5MSeptember 16, 2024 | Crypto 101 Media (Ad)Trader Books $13M Profit on “Nvidia of Crypto”A position trader recently booked an estimated $13.2 million profit on a single crypto currency… This little-known coin, dubbed the "Nvidia of crypto," is fueling the artificial intelligence boom – allowing top companies to train their AI systems without the need for expensive microchips.November 21, 2023 | finance.yahoo.comMedicure Reports Financial Results for Quarter Ended September 30, 2023October 24, 2023 | finance.yahoo.comMedicure Inc.'s (CVE:MPH) Stock Is Going Strong: Have Financials A Role To Play?October 2, 2023 | theglobeandmail.comMedicure: Top 10 Undervalued Drug Manufacturers Industry Stocks (MPH)August 25, 2023 | theglobeandmail.comClosing Bell: Medicure Inc flat on Thursday (MPH)August 15, 2023 | theglobeandmail.comClosing Bell: Medicure Inc flat on Monday (MPH)July 29, 2023 | theglobeandmail.comClosing Bell: Medicure Inc flat on Friday (MPH)July 29, 2023 | finance.yahoo.comMedicure Reports Financial Results For Quarter Ended June 30, 2023July 24, 2023 | finance.yahoo.comMedicure to Present Financial Results on July 31, 2023 Call at 8:30 AM ET for Quarter Ended June 30, 2023May 26, 2023 | finance.yahoo.comMedicure Reports Financial Results for Quarter Ended March 31, 2023See More Headlines Receive MCUJF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Medicure and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings8/14/2024Today9/16/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolOTCMKTS:MCUJF CUSIPN/A CIK1133519 Webwww.medicure.com Phone(204) 487-7412Fax204-488-9823EmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.08) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-680,000.00 Net Margins-12.46% Pretax Margin-12.10% Return on Equity-12.72% Return on Assets-9.15% Debt Debt-to-Equity Ratio0.01 Current Ratio1.87 Quick Ratio1.42 Sales & Book Value Annual Sales$16.07 million Price / Sales0.52 Cash Flow$0.09 per share Price / Cash Flow9.03 Book Value$1.41 per share Price / Book0.57Miscellaneous Outstanding Shares10,436,000Free Float9,090,000Market Cap$8.35 million OptionableNot Optionable Beta0.98 Beginners Guide To Retirement StocksClick the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report Key ExecutivesDr. Neil Owens Ph.D.President & COODr. Reuben Saba Ph.D.Vice President of Scientific & Medical AffairsDr. Albert David Friesen Ph.D. (Age 77)Founder, CEO & Chairman of the board Comp: $173.31kMr. Haaris Uddin B.Com.CPA, Chief Financial OfficerKey CompetitorsTempest TherapeuticsNASDAQ:TPSTAcurx PharmaceuticalsNASDAQ:ACXPEquilliumNASDAQ:EQLumos PharmaNASDAQ:LUMOAEON BiopharmaNASDAQ:AEONView All Competitors MCUJF Stock Analysis - Frequently Asked Questions How have MCUJF shares performed this year? Medicure's stock was trading at $0.7754 at the beginning of 2024. Since then, MCUJF stock has increased by 3.2% and is now trading at $0.80. View the best growth stocks for 2024 here. How were Medicure's earnings last quarter? Medicure Inc. (OTCMKTS:MCUJF) released its quarterly earnings data on Wednesday, August, 14th. The company reported ($0.09) earnings per share (EPS) for the quarter. The company had revenue of $3.78 million for the quarter. Medicure had a negative net margin of 12.46% and a negative trailing twelve-month return on equity of 12.72%. How do I buy shares of Medicure? Shares of MCUJF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:MCUJF) was last updated on 9/16/2024 by MarketBeat.com Staff From Our PartnersBREAKING NEWS: AI Tech Now Used to Stop School ShootersTwo seconds. That's all it takes for Knightscope's Automated Gunshot Detection to notify authorities and map a...Market JAR | SponsoredMore Than 30 Federal Agencies Buy From This Cybersecurity TechIn January of 2022 Ukraine was hit by an especially nasty piece of malware, named WhisperGate. By then Ukra...Capital Trends | SponsoredBiden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentia...Priority Gold | Sponsored44-year Wall Street Vet: “Permanent devastation is coming to America”After 44 years on Wall Street, I've seen it all... Black Monday, the Great Recession, the Covid crash. B...InvestorPlace | SponsoredBiden's Executive Order, Dems Digital Money Legislation, First Step ToDonald Trump once again sounded the alarm against Fed-controlled digital currencies (CBDCs). If these plans...Monetary Gold | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredAI Detects Profit Surge On MondayThis has given investors the opportunity to beat the market by 1,700% and a 100% win rate to begin the year.Monument Traders Alliance | Sponsored"Doomsday indicator” flashing for the first time since the Great Depression...It's been a bloodbath in the markets. The seven most valuable US tech companies lost a combined $1 trillion...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medicure Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Medicure With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MCUJF Stock Alerts